Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CymaBay Therapeutics, Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 215K | Jan 25, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | Chief Commercial Officer |
CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | Chief Commercial Officer |
CBAY | CymaBay Therapeutics, Inc. | May 10, 2021 | 1 | $0 | 4 | May 10, 2021 | Chief Commercial Officer |
CBAY | CymaBay Therapeutics, Inc. | May 10, 2021 | 0 | $0 | 3 | May 10, 2021 | Chief Commercial Officer |